ArticleBMJ open sport & exercise medicine2026
Evaluating the efficacy of a personalised sub-symptomatic exercise treatment programme for rehabilitation of military service members with persistent symptoms following mild traumatic brain injury: a randomised controlled trial.
Article in BMJ open sport & exercise medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mild traumatic brain injury (mTBI) remains a significant health concern for the US Military Health System and a threat to warfighter readiness. Although most service members (SMs) recover following an initial period of rest and a progressive return-to-activity protocol, a subset experience persistent cognitive, psychological and physical symptoms lasting months to years post-injury. Sub-symptomatic exercise has demonstrated efficacy in reducing exercise intolerance and expediting recovery in athletes with mTBI. Given differences in injury mechanisms between athletes and SMs, including blast exposure, it is unclear whether similar benefits extend to military populations with chronic post-concussive symptoms. This prospective, randomised controlled trial will evaluate the efficacy of an adaptable, sub-symptomatic exercise treatment (ASSET) programme compared with a mobility active control (MAC) intervention in SMs with chronic mTBI symptoms. A total of 140 active-duty SMs with a history of mTBI per Department of Defense criteria and persistently elevated neurobehavioural symptoms more than 1 month post-injury will be enrolled. Following screening and informed consent, participants will be randomised to ASSET or MAC and undergo baseline assessment. Outcomes will be assessed immediately postintervention (approximately 8 weeks) and at 3 months post-treatment. The primary outcome is neurobehavioural symptom resolution. Secondary and exploratory outcomes include cognitive performance, physiological adaptation, locomotion and military-relevant functional performance. Statistical analyses will examine group differences over time to determine treatment effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.